vs
Side-by-side financial comparison of Five9, Inc. (FIVN) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Five9, Inc. is the larger business by last-quarter revenue ($300.3M vs $151.7M, roughly 2.0× Nutex Health, Inc.). On growth, Five9, Inc. posted the faster year-over-year revenue change (7.8% vs -41.1%). Five9, Inc. produced more free cash flow last quarter ($77.3M vs $69.0M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 10.3%).
Five9, Inc. is a leading global provider of cloud-native contact center software and solutions. It serves enterprises of all sizes across retail, healthcare, financial services, and technology sectors, offering omnichannel customer engagement tools, AI-powered automation, workforce management, and analytics to boost customer experience and operational efficiency.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
FIVN vs NUTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $300.3M | $151.7M |
| Net Profit | — | $11.8M |
| Gross Margin | 55.4% | 30.4% |
| Operating Margin | 6.6% | 20.4% |
| Net Margin | — | 7.8% |
| Revenue YoY | 7.8% | -41.1% |
| Net Profit YoY | — | -80.8% |
| EPS (diluted) | $0.22 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $300.3M | $151.7M | ||
| Q3 25 | $285.8M | $267.8M | ||
| Q2 25 | $283.3M | $244.0M | ||
| Q1 25 | $279.7M | $211.8M | ||
| Q4 24 | $278.7M | $257.6M | ||
| Q3 24 | $264.2M | $78.8M | ||
| Q2 24 | $252.1M | $76.1M | ||
| Q1 24 | $247.0M | $67.5M |
| Q4 25 | — | $11.8M | ||
| Q3 25 | $18.0M | $55.4M | ||
| Q2 25 | $1.2M | $-17.7M | ||
| Q1 25 | $576.0K | $21.2M | ||
| Q4 24 | — | $61.6M | ||
| Q3 24 | $-4.5M | $-8.8M | ||
| Q2 24 | $-12.8M | $-364.0K | ||
| Q1 24 | $-7.1M | $-364.0K |
| Q4 25 | 55.4% | 30.4% | ||
| Q3 25 | 55.0% | 57.8% | ||
| Q2 25 | 54.9% | 51.2% | ||
| Q1 25 | 55.0% | 55.9% | ||
| Q4 24 | 56.0% | 55.0% | ||
| Q3 24 | 53.8% | 27.8% | ||
| Q2 24 | 53.0% | 29.7% | ||
| Q1 24 | 53.6% | 15.1% |
| Q4 25 | 6.6% | 20.4% | ||
| Q3 25 | 5.6% | 48.7% | ||
| Q2 25 | -0.6% | 13.8% | ||
| Q1 25 | -1.9% | 38.1% | ||
| Q4 24 | 1.5% | 44.4% | ||
| Q3 24 | -5.8% | 12.3% | ||
| Q2 24 | -7.7% | 7.0% | ||
| Q1 24 | -8.4% | 2.1% |
| Q4 25 | — | 7.8% | ||
| Q3 25 | 6.3% | 20.7% | ||
| Q2 25 | 0.4% | -7.3% | ||
| Q1 25 | 0.2% | 10.0% | ||
| Q4 24 | — | 23.9% | ||
| Q3 24 | -1.7% | -11.2% | ||
| Q2 24 | -5.1% | -0.5% | ||
| Q1 24 | -2.9% | -0.5% |
| Q4 25 | $0.22 | $2.34 | ||
| Q3 25 | $0.21 | $7.76 | ||
| Q2 25 | $0.01 | $-2.95 | ||
| Q1 25 | $0.01 | $3.33 | ||
| Q4 24 | $0.16 | $11.56 | ||
| Q3 24 | $-0.06 | $-1.72 | ||
| Q2 24 | $-0.17 | $-0.07 | ||
| Q1 24 | $-0.10 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $232.1M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $785.8M | $329.4M |
| Total Assets | $1.8B | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $232.1M | $185.6M | ||
| Q3 25 | $193.4M | $166.0M | ||
| Q2 25 | $205.5M | $96.7M | ||
| Q1 25 | $370.3M | $84.7M | ||
| Q4 24 | $362.5M | $40.6M | ||
| Q3 24 | $291.0M | $46.9M | ||
| Q2 24 | $175.7M | $40.8M | ||
| Q1 24 | $240.2M | $30.0M |
| Q4 25 | $785.8M | $329.4M | ||
| Q3 25 | $775.3M | $317.2M | ||
| Q2 25 | $717.4M | $235.3M | ||
| Q1 25 | $664.3M | $176.9M | ||
| Q4 24 | $622.2M | $132.4M | ||
| Q3 24 | $565.6M | $60.4M | ||
| Q2 24 | $525.9M | $62.7M | ||
| Q1 24 | $483.6M | $63.0M |
| Q4 25 | $1.8B | $918.5M | ||
| Q3 25 | $1.8B | $964.5M | ||
| Q2 25 | $1.7B | $841.0M | ||
| Q1 25 | $2.1B | $761.9M | ||
| Q4 24 | $2.1B | $655.3M | ||
| Q3 24 | $2.0B | $438.5M | ||
| Q2 24 | $1.9B | $422.4M | ||
| Q1 24 | $1.9B | $404.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $83.6M | $70.4M |
| Free Cash FlowOCF − Capex | $77.3M | $69.0M |
| FCF MarginFCF / Revenue | 25.8% | 45.5% |
| Capex IntensityCapex / Revenue | 2.1% | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $201.2M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $83.6M | $70.4M | ||
| Q3 25 | $59.2M | $99.5M | ||
| Q2 25 | $35.1M | $27.3M | ||
| Q1 25 | $48.4M | $51.0M | ||
| Q4 24 | $49.8M | $54.0K | ||
| Q3 24 | $41.1M | $6.8M | ||
| Q2 24 | $19.9M | $13.3M | ||
| Q1 24 | $32.4M | $3.1M |
| Q4 25 | $77.3M | $69.0M | ||
| Q3 25 | $48.7M | $99.2M | ||
| Q2 25 | $31.6M | $26.5M | ||
| Q1 25 | $43.7M | $50.9M | ||
| Q4 24 | $40.5M | $-341.0K | ||
| Q3 24 | $26.7M | $6.2M | ||
| Q2 24 | $13.1M | $12.7M | ||
| Q1 24 | $20.4M | $2.3M |
| Q4 25 | 25.8% | 45.5% | ||
| Q3 25 | 17.0% | 37.0% | ||
| Q2 25 | 11.1% | 10.9% | ||
| Q1 25 | 15.6% | 24.0% | ||
| Q4 24 | 14.5% | -0.1% | ||
| Q3 24 | 10.1% | 7.8% | ||
| Q2 24 | 5.2% | 16.7% | ||
| Q1 24 | 8.3% | 3.4% |
| Q4 25 | 2.1% | 0.9% | ||
| Q3 25 | 3.7% | 0.1% | ||
| Q2 25 | 1.2% | 0.3% | ||
| Q1 25 | 1.7% | 0.0% | ||
| Q4 24 | 3.3% | 0.2% | ||
| Q3 24 | 5.4% | 0.8% | ||
| Q2 24 | 2.7% | 0.7% | ||
| Q1 24 | 4.8% | 1.1% |
| Q4 25 | — | 5.95× | ||
| Q3 25 | 3.29× | 1.80× | ||
| Q2 25 | 30.38× | — | ||
| Q1 25 | 84.00× | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FIVN
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
